Clinical Trial Update: Sequential CD146 and GPC3 CAR-T Cell Therapy in Advanced Ovarian Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating sequential CD146 and GPC3 CAR-T cell therapy for advanced ovarian cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Ovarian Sarcoma

Drugs mentioned

• CD146 CAR-T cell therapy (CD146-directed CAR-T cell therapy)
• GPC3 CAR-T cell therapy (GPC3-directed CAR-T cell therapy)

Snippet

Sponsor: Essen Biotech | Conditions: Ovarian Cancer, Ovarian Carcinoma | Phase 1, Phase 2 | Status: RECRUITING